高抗苗勒管激素水平与接受IVF/ICSI-ET的多囊卵巢综合征患者妊娠期高血压相关
本研究为回顾性研究,纳入649例接受新鲜胚胎移植后单胎活产的多囊卵巢综合征(PCOS)患者,分析血清抗苗勒管激素(AMH)与妊娠期高血压的关联。结果显示,妊娠期高血压患者AMH水平高于无妊娠期高血压者;AMH每升高1 ng/mL,妊娠期高血压的比值比在未调整时为1.117,调整后为1.186。AMH>9.30 ng/mL组调整后OR为2.635,>12.31 ng/mL组调整后OR为4.75;倾向性评分匹配后关联仍存在。
要点
- PCOS患者新鲜胚胎移植后,妊娠期高血压者AMH水平高于无妊娠期高血压者。
- AMH每升高1 ng/mL,妊娠期高血压调整后OR为1.186(95%CI 1.061-1.327)。
- AMH>9.30 ng/mL组妊娠期高血压调整后OR为2.635(95%CI 1.132-6.137)。
核心结论
- 孕前高血清AMH水平(尤其>9.30 ng/mL)提示接受新鲜胚胎移植的PCOS患者妊娠期高血压的比值比较高。
研究设计与样本
- 回顾性研究,纳入649例接受新鲜胚胎移植后单胎活产的PCOS患者,采用倾向性评分匹配前后评估AMH与妊娠期高血压的关联。
主要发现
- 妊娠期高血压患者AMH水平高于无妊娠期高血压者。
- 单因素logistic回归中,AMH每升高1 ng/mL,妊娠期高血压的比值比增加11.7%(OR 1.117;95%CI 1.025-1.217;P=.012)。
- 调整混杂因素后,AMH每升高1 ng/mL,妊娠期高血压的比值比增加18.6%(调整OR 1.186;95%CI 1.061-1.327;调整P=.003)。
- 与无妊娠期高血压组相比,AMH>9.30 ng/mL(第75百分位组)的妊娠期高血压调整OR为2.635(95%CI 1.132-6.137;调整P=.025),增加超过100%。
- 与无妊娠期高血压组相比,AMH>12.31 ng/mL(第90百分位组)的妊娠期高血压调整OR为4.75(95%CI 1.672-13.495;调整P=.003),增加超过3倍。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patients with polycystic ovary syndrome (PCOS) have a higher risk of obstetric complications. The association between anti-Müllerian hormone (AMH) and gestational hypertension in these patients is poorly understood. OBJECTIVE: To determine the association between serum AMH levels and gestational hypertension in patients with PCOS undergoing fresh embryo transfer. METHODS: This retrospective study included 649 patients with PCOS who had singleton live births after undergoing fresh embryo transfers. The association of AMH with gestational hypertension in these patients was estimated before and after propensity score matching. RESULTS: Patients with gestational hypertension had higher AMH levels than those without gestational hypertension. In single-factor logistic regression, the odds of gestational hypertension increased by 11.7% and 18.6% for every 1ng/mL increase in AMH before and after adjusting for confounding factors (odds ratio [OR], 1.117; 95% CI, 1.025-1.217; P = .012; adjusted OR, 1.186; 95% CI, 1.061-1.327; adjusted P = .003), respectively. The odds of gestational hypertension increased more than 100% (adjusted OR, 2.635; 95% CI, 1.132-6.137; adjusted P = .025) in the 75th percentile group (>9.30 ng/mL) and more than 3 times (adjusted OR, 4.75; 95% CI, 1.672-13.495; adjusted P = .003) in the 90th percentile group (>12.31 ng/mL) compared to the without gestational hypertension group. AMH level was still associated with gestational hypertension after propensity score matching. The area under the curve of AMH predicting gestational hypertension was 0.654 (95% CI, 0.532-0.776; P = .011) with an optimal cutoff value of 11.975 ng/mL. CONCLUSION: High serum AMH level prepregnancy (especially at levels >9.30 ng/mL) indicates a high odds of gestational hypertension in patients with PCOS undergoing fresh embryo transfer.
引用
- Zhang M, Liu S, Zhang F, et al. High AMH Levels Are Associated With Gestational Hypertension in Patients With PCOS who Underwent IVF/ICSI-ET. J Clin Endocrinol Metab. 2025. PMID: 38739541. doi:10.1210/clinem/dgae324
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。